Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Pancreatic Neoplasms × toripalimab × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Solid Tumor 10 Solid Tumor 5 Uterine Cervical Neoplasms 4 Nasopharyngeal Carcinoma 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Hepatocellular 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Locally Advanced or Metastatic Solid Tumors 2 Endometrial Neoplasms 2 Advanced Solid Tumors 2 Advanced Lung Cancer 2 Stomach Neoplasms 1 Solid Tumor, Adult 1 Solid Cancer 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 PD-1 1 Ovarian Neoplasms 1 Meningeal Carcinomatosis 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Liposarcoma 1 Head and Neck Squamous Cell Cancer 1

Interventions

Gemcitabine 87 130-nm albumin-bound paclitaxel 44 Albumin-Bound Paclitaxel 34 Oxaliplatin 25 Fluorouracil 25 Capecitabine 20 Leucovorin 19 Taxes 18 pembrolizumab 16 Irinotecan 16 Cyclophosphamide 16 Cetuximab 11 Bevacizumab 11 Nivolumab 10 Cisplatin 10 fludarabine 9 durvalumab 7 aldesleukin 7 Radiotherapy 7 spartalizumab 6 Radiosurgery 6 Paclitaxel 6 irinotecan sucrosofate 5 avelumab 5 Injections 5 Erlotinib Hydrochloride 5 ALT-803 5 folfirinox 4 dehydroftorafur 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06370754 2024-04-17

FD-IMPACT

Fudan University

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡